Cancer Keys: Brain Tumours and Headaches

Latest from the Blog

Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more

Related Posts

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more

Whilst many people may associate brain tumours with headaches, often affected patients do not present with a headache until a later stage, if at all.

Potential pitfall:

Only up to 16% of brain tumour patients present to their GP with an isolated headache*; some diagnosed patients will never develop a headache. It is important to be vigilant for other progressive neurological symptoms including visual field loss, personality changes or new-onset seizures.

Helpful hint:

NICE NG12 guidelines advise an urgent direct access MRI (or CT) scan within two weeks for adults with progressive, sub-acute loss of central neurological function (or a suspected cancer referral if MRI/CT unavailable), or a very urgent referral (within 48 hours) for children and young people with newly abnormal cerebellar or other central neurological function.

Cancer Keys are brought to you by GatewayC.

Find out more: 

Register for GatewayC’s FREE Webinar: Headache or Brain Tumour? here

Download this Cancer Key here.

Access GatewayC’s Brain Tumour – Early Diagnosis course here.

*Pract, J. (2008) Imaging patients with suspected brain tumour: guidance for primary care 

Estimates of the proportion of patients with tumour who present with isolated headache range between 2% and 16%

LinkedIn Twitter Facebook

Latest from the Blog

Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more

Related Posts

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more